ArticleCureus2025
Unraveling the Complexity: A Case of Systemic Lupus Erythematosus, Warm Autoimmune Hemolytic Anemia, and Autoimmune Cholangitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE), warm autoimmune hemolytic anemia (WAIHA), and autoimmune cholangitis (AIC) are three distinct autoimmune conditions, each posing its own clinical challenges. The coexistence of these diseases in a single patient, however, is exceedingly rare and presents a complex diagnostic and therapeutic dilemma. SLE is an autoimmune disease that can cause a constellation of pathologies that affect various organs. WAIHA involves the premature destruction of red blood cells due to immunoglobulin (IgG) autoantibodies, leading to hemolytic anemia. AIC is characterized by features of both autoimmune hepatitis and cholestatic liver disease, which adds further complexity to this overlap syndrome. Herein presented is a case of a patient with simultaneous SLE, WAIHA, and AIC, highlighting the overlapping symptoms, diagnostic challenges, and the multifaceted approach to management. The case underscores the importance of a comprehensive, multidisciplinary approach to address the interplay of multiple autoimmune disorders, given the risk of therapeutic conflicts and disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.